Avadel Pharmaceuticals (AVDL) Other Non Operating Income (2016 - 2020)
Historic Other Non Operating Income for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q2 2020 value amounting to -$125000.0.
- Avadel Pharmaceuticals' Other Non Operating Income fell 15000.0% to -$125000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was -$125000.0, marking a year-over-year increase of 6719.16%. This contributed to the annual value of -$435000.0 for FY2020, which is 1507.94% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Other Non Operating Income stood at -$125000.0 for Q2 2020, which was down 15000.0% from -$310000.0 recorded in Q1 2020.
- Avadel Pharmaceuticals' Other Non Operating Income's 5-year high stood at $1.7 million during Q2 2017, with a 5-year trough of -$2.9 million in Q1 2016.
- Its 5-year average for Other Non Operating Income is -$266555.6, with a median of -$132000.0 in 2019.
- Its Other Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 16022.36% in 2017, then plummeted by 17181.82% in 2018.
- Quarter analysis of 5 years shows Avadel Pharmaceuticals' Other Non Operating Income stood at -$413000.0 in 2016, then plummeted by 122.03% to -$917000.0 in 2017, then soared by 150.93% to $467000.0 in 2018, then plummeted by 74.73% to $118000.0 in 2019, then plummeted by 205.93% to -$125000.0 in 2020.
- Its Other Non Operating Income stands at -$125000.0 for Q2 2020, versus -$310000.0 for Q1 2020 and $118000.0 for Q4 2019.